News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: Shanghai Pharma Bids In Cardinal China's $1.5 Billion Auction
Shanghai Pharma (SHA: 601607) and FountainVest Partners, a China private equity fund, have submitted second-round bids for Cardinal China's (NYSE: CAH​) drug distribution operations.
Read
Week In Review: Fosun May Pay $350 Million For Second India Pharma Acquisition
Shanghai Fosun Pharma (SHA: 600196; HK: 2196) is one of the companies bidding to acquire a 70% stake in India's Symbiotec Pharma, which supplies steroid-hormone APIs to global markets.
Read
Week In Review: Another Billion Dollar Week For China Life Science Deals
Shanghai Pharma Holding (SHA: 601607) may acquire part of Alvogen -- possibly Alvogen's US operations -- according to Bloomberg. Alvogen is a US-based generic drug maker thought to be worth as much as $4 billion.
Read
Week In Review: Zai Lab Completes $150 Million US IPO; Investors Push Valuation To $1.4 Billion
Zai Lab raised $150 million in its US IPO after the company increased the size of the offering to 8 million shares. Demand for the offering was strong, and Zai's stock opened 50% above the IPO price at $27 per share.
Read
Week In Review: Shanghai United Imaging Raises $500 Million In Series A; Zai Lab Will IPO Next Week
Shanghai United Imaging Healthcare's recent financing from large China investors is the largest medical device funding in China to date, and values Shanghai United at $5 billion.
Read
Week In Review: China Pharma Continues Record Deal Pace With $2 Billion In New Announcements
OrbiMed, a global healthcare investor, closed its third Asia private equity fund with $551 million in capital commitments, about $100 million more than the target listed in its initial filing six months ago.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week In Review: Shanghai Pharma Bids In Cardinal China's $1.5 Billion Auction $CAH $CAH $CASI $CBPO $BIIB https://t.co/bibgL5oLQT less
ChinaBio® Today
Week In Review: Fosun May Pay $350 Million For Second India Pharma Acquisition https://t.co/00CrUDO2oD
ChinaBio® Today
Week in Review: Another Billion Dollar Week For China Life Science Deals $NVO ...

more
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications